These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37252318)

  • 41. Chromosomal changes in fibrolamellar hepatocellular carcinoma detected by array comparative genomic hybridization.
    Kakar S; Chen X; Ho C; Burgart LJ; Sahai V; Dachrut S; Yabes A; Jain D; Ferrell LD
    Mod Pathol; 2009 Jan; 22(1):134-41. PubMed ID: 18997738
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Applications of Flow Cytometric Immunophenotyping in the Diagnosis and Posttreatment Monitoring of B and T Lymphoblastic Leukemia/Lymphoma.
    DiGiuseppe JA; Wood BL
    Cytometry B Clin Cytom; 2019 Jul; 96(4):256-265. PubMed ID: 31231940
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metastatic nonresectable fibrolamellar hepatoma: prognostic features and natural history.
    Epstein BE; Pajak TF; Haulk TL; Herpst JM; Order SE; Abrams RA
    Am J Clin Oncol; 1999 Feb; 22(1):22-8. PubMed ID: 10025374
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fibrolamellar carcinoma of the liver exhibits immunohistochemical evidence of both hepatocyte and bile duct differentiation.
    Ward SC; Huang J; Tickoo SK; Thung SN; Ladanyi M; Klimstra DS
    Mod Pathol; 2010 Sep; 23(9):1180-90. PubMed ID: 20495535
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An unusual presentation of precursor T cell lymphoblastic leukemia/lymphoma with cholestatic jaundice: case report.
    Patel KJ; Latif SU; de Calaca WM
    J Hematol Oncol; 2009 Mar; 2():12. PubMed ID: 19284608
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Indolent T-lymphoblastic proliferation: a name with specific meaning.
    Ohgami RS; Natkunam Y; Warnke RA
    Hum Pathol; 2015 Nov; 46(11):1785-6. PubMed ID: 26363525
    [No Abstract]   [Full Text] [Related]  

  • 47. The fibrolamellar variant of hepatocellular carcinoma. Its association with focal nodular hyperplasia.
    Saul SH; Titelbaum DS; Gansler TS; Varello M; Burke DR; Atkinson BF; Rosato EF
    Cancer; 1987 Dec; 60(12):3049-55. PubMed ID: 2824023
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Indolent T-lymphoblastic proliferation: a name with specific meaning--reply.
    Nathwani BN; Kansal R; Yiakoumis X; Pangalis GA
    Hum Pathol; 2015 Nov; 46(11):1786-7. PubMed ID: 26410056
    [No Abstract]   [Full Text] [Related]  

  • 49. [Hepatocellular carcinoma--from macroscopy to molecular pathology].
    Schaff Z; Kovalszky I; Lotz G; Kiss A
    Orv Hetil; 2010 Jun; 151(24):982-9. PubMed ID: 20519181
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fibrolamellar hepatocellular carcinoma.
    Liu S; Chan KW; Wang B; Qiao L
    Am J Gastroenterol; 2009 Oct; 104(10):2617-24; quiz 2625. PubMed ID: 19638962
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clinicopathologic features and prognosis of T lymphoblastic lymphoma associated with Langerhans cell histiocytosis].
    Li X; Wang Y; Chen R; Abulaiti D; Ma Z; Miao N; Abulajiang G; Zhang W
    Zhonghua Bing Li Xue Za Zhi; 2014 Aug; 43(8):522-7. PubMed ID: 25346121
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Precursor B- or T-lymphoblastic lymphoma presenting with cutaneous involvement: a series of 13 cases including 7 cases of cutaneous T-lymphoblastic lymphoma.
    Lee WJ; Moon HR; Won CH; Chang SE; Choi JH; Moon KC; Lee MW
    J Am Acad Dermatol; 2014 Feb; 70(2):318-25. PubMed ID: 24314877
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Diagnosis and differential diagnosis of hepatocellular carcinoma].
    Drebber U; Dienes HP
    Pathologe; 2006 Jul; 27(4):294-9. PubMed ID: 16767425
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Hepatocellular nodular hyperplasias, adenomas and carcinomas].
    Altmann HW
    Verh Dtsch Ges Pathol; 1995; 79():84-108. PubMed ID: 8600698
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.
    Schoedel KE; Tyner VZ; Kim TH; Michalopoulos GK; Mars WM
    Mod Pathol; 2003 Jan; 16(1):14-21. PubMed ID: 12527708
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatocellular carcinoma coexistent with adenomatous hyperplasia: report of a case.
    Kurita K; Yoshida A; Tanabe G; Shirao K; Hamanoue M; Aikou T; Shimazu H
    Surg Today; 1993; 23(6):528-31. PubMed ID: 8395266
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sirolimus for the Treatment of Airway Obstruction due to Indolent T-Lymphoblastic Proliferation.
    Moughames E; Kiess AP; Akst LM; Azar A
    Case Reports Immunol; 2019; 2019():1724083. PubMed ID: 31976096
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fibrolamellar hepatocellular carcinoma "it is not a ordinary case for Mediterranean countries".
    Arslan I; Oner K; Kilicturgay S; Agar N; Alpaslan F
    HPB Surg; 1995; 9(1):51-3. PubMed ID: 8857455
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fibrolamellar carcinoma of the liver: CT, ultrasound and angiography. Case report.
    Bedi DG; Kumar R; Morettin LB; Gourley K
    Eur J Radiol; 1988 May; 8(2):109-12. PubMed ID: 2838279
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinicopathological and immunophenotypic features of early T cell precursor acute lymphoblastic leukaemia: A flow cytometry score for the initial diagnosis.
    Chandra D; Singh MK; Gupta R; Rahman K; Yadav DD; Sarkar MK; Gupta A; Yadav S; Kashyap R; Nityanand S
    Int J Lab Hematol; 2021 Dec; 43(6):1417-1423. PubMed ID: 34115925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.